These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15582991)

  • 1. Glycosaminoglycans modulate activation, activity, and stability of tripeptidyl-peptidase I in vitro and in vivo.
    Golabek AA; Walus M; Wisniewski KE; Kida E
    J Biol Chem; 2005 Mar; 280(9):7550-61. PubMed ID: 15582991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase I.
    Golabek AA; Kida E; Walus M; Wujek P; Mehta P; Wisniewski KE
    J Biol Chem; 2003 Feb; 278(9):7135-45. PubMed ID: 12488460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prosegment of tripeptidyl peptidase I is a potent, slow-binding inhibitor of its cognate enzyme.
    Golabek AA; Dolzhanskaya N; Walus M; Wisniewski KE; Kida E
    J Biol Chem; 2008 Jun; 283(24):16497-504. PubMed ID: 18411270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-glycosylation is crucial for folding, trafficking, and stability of human tripeptidyl-peptidase I.
    Wujek P; Kida E; Walus M; Wisniewski KE; Golabek AA
    J Biol Chem; 2004 Mar; 279(13):12827-39. PubMed ID: 14702339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturation of human tripeptidyl-peptidase I in vitro.
    Golabek AA; Wujek P; Walus M; Bieler S; Soto C; Wisniewski KE; Kida E
    J Biol Chem; 2004 Jul; 279(30):31058-67. PubMed ID: 15143070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
    Bernardini F; Warburton MJ
    Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lysosomal degradation of neuromedin B is dependent on tripeptidyl peptidase-I: evidence for the impairment of neuropeptide degradation in late-infantile neuronal ceroid lipofuscinosis.
    Kopan S; Sivasubramaniam U; Warburton MJ
    Biochem Biophys Res Commun; 2004 Jun; 319(1):58-65. PubMed ID: 15158442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tripeptidyl-peptidase I in neuronal ceroid lipofuscinoses and other lysosomal storage disorders.
    Wisniewski KE; Kida E; Walus M; Wujek P; Kaczmarski W; Golabek AA
    Eur J Paediatr Neurol; 2001; 5 Suppl A():73-9. PubMed ID: 11589013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tripeptidyl peptidase-I is essential for the degradation of sulphated cholecystokinin-8 (CCK-8S) by mouse brain lysosomes.
    Warburton MJ; Bernardini F
    Neurosci Lett; 2002 Oct; 331(2):99-102. PubMed ID: 12361850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH.
    Lin L; Sohar I; Lackland H; Lobel P
    J Biol Chem; 2001 Jan; 276(3):2249-55. PubMed ID: 11054422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis.
    Guhaniyogi J; Sohar I; Das K; Stock AM; Lobel P
    J Biol Chem; 2009 Feb; 284(6):3985-97. PubMed ID: 19038967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase.
    Ezaki J; Takeda-Ezaki M; Kominami E
    J Biochem; 2000 Sep; 128(3):509-16. PubMed ID: 10965052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tripeptidyl-peptidase I--distribution, biogenesis, and mechanisms of activation].
    Gołabek AA
    Postepy Biochem; 2006; 52(1):16-23. PubMed ID: 16869297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ser475, Glu272, Asp276, Asp327, and Asp360 are involved in catalytic activity of human tripeptidyl-peptidase I.
    Walus M; Kida E; Wisniewski KE; Golabek AA
    FEBS Lett; 2005 Feb; 579(6):1383-8. PubMed ID: 15733845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I.
    Vines DJ; Warburton MJ
    FEBS Lett; 1999 Jan; 443(2):131-5. PubMed ID: 9989590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis.
    Ezaki J; Takeda-Ezaki M; Oda K; Kominami E
    Biochem Biophys Res Commun; 2000 Feb; 268(3):904-8. PubMed ID: 10679303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The substrate range of tripeptidyl-peptidase I.
    Bernardini F; Warburton MJ
    Eur J Paediatr Neurol; 2001; 5 Suppl A():69-72. PubMed ID: 11589011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis.
    Lin L; Lobel P
    Biochem J; 2001 Jul; 357(Pt 1):49-55. PubMed ID: 11415435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of tripeptidyl peptidase I in human tissues under normal and pathological conditions.
    Kida E; Golabek AA; Walus M; Wujek P; Kaczmarski W; Wisniewski KE
    J Neuropathol Exp Neurol; 2001 Mar; 60(3):280-92. PubMed ID: 11245212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes.
    Steinfeld R; Steinke HB; Isbrandt D; Kohlschütter A; Gärtner J
    Hum Mol Genet; 2004 Oct; 13(20):2483-91. PubMed ID: 15317752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.